Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04782557

EUS Guided HVA and PVA for Circulating Tumor DNA in Patients

Endoscopic Ultrasound Guided Hepatic and Portal Vein Aspiration for Circulating Tumor DNA in Patients Suffering From GI Cancers

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The discovery of cell-free circulating tumor DNA (crDNA) in blood and the maturation of technologies for ctDNA analysis have presented an attractive opportunity for minimally invasive "liquid biopsy" genomic diagnostics. The investigators plan to perform EUS-guided portal vein and hepatic vein aspiration in GI cancers patients. The aim of the current study is thus to examine the concentration of ctDNA in portal vein (EUS-guided PVA), hepatic vein (EUS-guided HVA) and peripheral blood to understand the first pass effect of the liver with gastrointestinal (GI) cancers, and the possibility of using ctDNA as a marker for preoperative staging, restaging after neoadjuvant chemotherapy, and monitoring for recurrence.

Detailed description

The discovery of cell-free circulating tumor DNA (crDNA) in blood and the maturation of technologies for ctDNA analysis have presented an attractive opportunity for minimally invasive "liquid biopsy" genomic diagnostics. The investigators plan to perform EUS-guided portal vein and hepatic vein aspiration in GI cancers patients. The aim of the current study is thus to examine the concentration of ctDNA in portal vein (EUS-guided PVA), hepatic vein (EUS-guided HVA) and peripheral blood to understand the first pass effect of the liver with gastrointestinal (GI) cancers, and the possibility of using ctDNA as a marker for preoperative staging, restaging after neoadjuvant chemotherapy, and monitoring for recurrence.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEUS-guided portal vein and hepatic vein aspirationEUS-guided portal vein and hepatic vein aspiration

Timeline

Start date
2021-01-01
Primary completion
2026-01-01
Completion
2026-12-31
First posted
2021-03-04
Last updated
2021-03-04

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04782557. Inclusion in this directory is not an endorsement.